All news


Precautionary recall of some Valsartan blood pressure and heart medicines

The Health Products Regulatory Authority (HPRA) have alerted Actavis Ireland Limited (part of the Accord Healthcare group) that there is a potential impurity issue with the supply of Valsartan active substance from a third-party facility.

We have taken immediate steps to recall the drug at a pharmacy level in accordance with HPRA guidelines. At present there is no evidence that this impurity has caused any harm to patients and the recall is a precautionary measure.
Patients prescribed Valsartan should speak to their local healthcare professional for further advice.

To view our letter to pharmacists please click here

All news